國立虎尾科技大學 |

Controversies in Cardiology

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Controversies in Cardiology/ edited by John A. Ambrose, Alfredo E. Rodríguez.
其他作者:	Ambrose, John A.
面頁冊數:	XVIII, 417 p. 53 illus., 41 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Cardiology. -
電子資源:	https://doi.org/10.1007/978-3-319-20415-4
ISBN:	9783319204154

Controversies in Cardiology
Controversies in Cardiology[electronic resource] /edited by John A. Ambrose, Alfredo E. Rodríguez. - 1st ed. 2015. - XVIII, 417 p. 53 illus., 41 illus. in color.online resource.

Section 1. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Section 2. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women – evaluation and management -- Section 3. Cardiovascular management -- Myocardial infarction and “normal” coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease – PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes – does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access? -- Cost benefits of TAVR- Should the indications be expanded?.

This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients.

ISBN: 9783319204154

Standard No.: 10.1007/978-3-319-20415-4doiSubjects--Topical Terms:

593957
Cardiology.

LC Class. No.: RC681-688.2

Dewey Class. No.: 616.12

Controversies in Cardiology
LDR:03969nam a22003855i 4500 001 965249
003 DE-He213
005 20200701080117.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319204154 $9 978-3-319-20415-4
024 7 $a 10.1007/978-3-319-20415-4 $2 doi
035 $a 978-3-319-20415-4
050 4 $a RC681-688.2
072 7 $a MJD $2 bicssc
072 7 $a MED010000 $2 bisacsh
072 7 $a MJD $2 thema
082 0 4 $a 616.12 $2 23
245 1 0 $a Controversies in Cardiology $h [electronic resource] / $c edited by John A. Ambrose, Alfredo E. Rodríguez.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XVIII, 417 p. 53 illus., 41 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Section 1. Special situations of controversial, increased, or unknown cardiovascular risk -- Optimal management of old and new CV risk factors -- Angiographic narrowing prior to ST elevation MI. Are the lesions non-obstructive? -- Preventing future acute coronary events - Identify and treat vulnerable plaques or vulnerable, high risk patients? -- Treatment of diabetes and coronary artery disease -- Elevated triglycerides and atherosclerosis -- Patent foramen ovale and stroke -- Systolic hypertension in the elderly -- Section 2. Cardiovascular diagnosis -- CT angiography vs routine stress testing in patients with chest pain seen in the emergency room to exclude coronary artery disease -- Takotsubo cardiomyopathy- frequency, diagnosis and management -- Chest pain in women – evaluation and management -- Section 3. Cardiovascular management -- Myocardial infarction and “normal” coronary arteries on angiography -- Management of intractable angina when PCI or CABG is not an option -- Invasive management of CAD in patients on anticoagulants -- Managing intracoronary thrombus during PCI -- Optimal management of multivessel disease – PCI vs CABG vs medical therapy alone -- Appropriate therapy for severe left main disease -- Radial vs femoral procedures for angiography and PCI -- DAPT after stenting in stable and acute coronary syndromes – does the drug combination really matter? -- CAD management in patients with significant renal dysfunction or on dialysis -- What is the optimal stent design? -- Oral pharmacotherapy in the prevention of restenosis: prednisolone, rapamune, colchicine and cilostazol -- When should ablation be considered in the treatment of atrial fibrillation? -- Use of advanced and expensive cardiac procedures in the very elderly- Can or should we limit access? -- Cost benefits of TAVR- Should the indications be expanded?.
520 $a This book considers several clinical and interventional topics for which there is either uncertainty, continued debate and/or no consensus based on current guidelines. Leading international experts explore each controversy, probing the existing evidence and current opinions. Each chapter outlines the unresolved issues and includes a balanced and scholarly discussion of the subject, concluding with possible solutions and learned opinions on the subject. While there are many guidelines in cardiology, new and on-going trials that address new treatments indicate that there are still many unanswered questions. Controversies in Cardiology provides a concise approach to aid busy cardiologists and trainees in choosing the most suitable management solutions and correctly applying these to their patients.
650 0 $a Cardiology. $3 593957
650 0 $a Minimally invasive surgery. $3 1128631
650 0 $a Cardiac surgery. $3 1254013
650 2 4 $a Minimally Invasive Surgery. $3 673841
650 2 4 $a Cardiac Surgery. $3 673715
700 1 $a Ambrose, John A. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1070061
700 1 $a Rodríguez, Alfredo E. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1260830
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319204147
776 0 8 $i Printed edition: $z 9783319204161
856 4 0 $u https://doi.org/10.1007/978-3-319-20415-4
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)